SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-057993
Filing Date
2017-11-13
Accepted
2017-11-13 09:01:32
Documents
51
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv478357_10q.htm 10-Q 359079
2 EXHIBIT 31.1 tv478357_ex31-1.htm EX-31.1 8440
3 EXHIBIT 31.2 tv478357_ex31-2.htm EX-31.2 8269
4 EXHIBIT 32.1 tv478357_ex32-1.htm EX-32.1 4117
5 EXHIBIT 32.2 tv478357_ex32-2.htm EX-32.2 4037
  Complete submission text file 0001144204-17-057993.txt   2729452

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rprx-20170930.xml EX-101.INS 516819
7 XBRL TAXONOMY EXTENSION SCHEMA rprx-20170930.xsd EX-101.SCH 31974
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rprx-20170930_cal.xml EX-101.CAL 23033
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rprx-20170930_def.xml EX-101.DEF 190172
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rprx-20170930_lab.xml EX-101.LAB 212448
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rprx-20170930_pre.xml EX-101.PRE 218677
Mailing Address 2408 TIMBERLOCH PLACE B-7 THE WOODLANDS TX 77380
Business Address 2408 TIMBERLOCH PL SUITE B-7 WOODLANDS TX 77380 2817193400
REPROS THERAPEUTICS INC. (Filer) CIK: 0000897075 (see all company filings)

IRS No.: 760233274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15281 | Film No.: 171193445
SIC: 2836 Biological Products, (No Diagnostic Substances)